Nakatsu, Japan

Michio Terazawa

This inventor holds 1 USPTO granted patent. Top assignee: Yoshitomi Pharmaceutical Industries, Ltd.. Active years: 1981.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michio Terazawa. Retrieved from https://idiyas.com/inventor/michio-terazawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1981

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michio Terazawa: Innovator in Rheumatism Treatment

Introduction

Michio Terazawa is a notable inventor from Nakatsu, Japan, recognized for his contributions to the field of medicine. He has developed a unique method for treating rheumatism, showcasing his innovative spirit and dedication to improving patient care.

Latest Patents

Terazawa holds a patent for a method of treating rheumatism. This method involves the administration of 9-chloro-7-(1H-tetrazol-5-yl)-5-oxo-5H-[1H]benzopyrano[2,3-b]pyridine, along with its salt and hydrate forms. This innovative approach aims to provide relief for individuals suffering from this debilitating condition.

Career Highlights

Throughout his career, Michio Terazawa has been associated with Yoshitomi Pharmaceutical Industries, Ltd., where he has contributed significantly to pharmaceutical research and development. His work has been instrumental in advancing treatment options for rheumatism.

Collaborations

Some of his notable coworkers include Yutaka Maruyama and Kazuhiro Goto, who have collaborated with him on various projects within the pharmaceutical industry.

Conclusion

In summary, Michio Terazawa is a distinguished inventor whose work in rheumatism treatment has made a significant impact in the medical field. His innovative methods and dedication to research continue to inspire advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…